v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
OPERATING ACTIVITIES:    
Net (loss) income $ (662,086) $ 1,810,321
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Gain on sale of assets   (2,820,668)
Change in fair value of derivative liability (150,635)  
Depreciation 1,135  
Amortization of original issue discount and accrued interest on convertible debt 99,839  
Deferred income taxes   361,000
Changes in operating assets and liabilities:    
Decrease in accounts receivable and amount due from factor 1,208 1,579,321
(Increase) decrease in inventories and prepaid expenses (103,842) 3,768,052
Increase (decrease) in accounts payable 96,330 (1,980,177)
Decrease in assets - held for sale   (1,681,937)
Direct debt issuance costs paid, classified as a financing activity 30,000  
Increase in accrued liabilities 246 47,591
Decrease in operating lease liability   (13,330)
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES (687,805) 1,070,173
INVESTING ACTIVITIES:    
Proceeds from sale of assets   4,955,108
Decrease in trade accounts payable related to closing costs on sale   (452,503)
Purchase of fixed asset (45,401)  
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (45,401) 4,502,605
FINANCING ACTIVITIES:    
Proceeds from the issuance of convertible debt, net of discount 1,000,000  
Convertible debt issuance costs (30,000)  
Net repayment - line of credit - factor   (2,100,458)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 970,000 (2,100,458)
NET INCREASE IN CASH 236,794 3,472,320
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 3,473,619 348,074
CASH AND CASH EQUIVALENTS AT END OF PERIOD 3,710,413 $ 3,820,394
Non-cash supplemental Information:    
Convertible notes settled through issuance of common stock (682,507)  
Reclassification of derivative liability to additional paid in capital upon settlement of convertible notes $ (204,365)